How Many Doses Are in the Ozempic 0.25 mg and 0.5 mg Starter Pen?

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Ozempic 0.25/0.5 mg pen (red label) contains exactly 2 mg of semaglutide, delivering 4 doses at 0.25 mg or 2 doses at 0.5 mg, not both from the same pen
• The dose counter shows only "1" and "2" because it counts flows, not milligram amounts, and each flow delivers different doses depending on where you started
• Most patients use one pen for their first month (4 weeks at 0.25 mg), then switch to a new pen for 0.5 mg dosing, requiring 2 pens total for the standard 8-week titration
• The pen cannot be reset, refilled, or adjusted backward once a dose is selected, and any attempt to force the mechanism damages the pen and wastes medication

Direct answer (40-60 words)

The Ozempic 0.25/0.5 mg pen contains 2 mg of semaglutide total. It delivers exactly 4 doses at the 0.25 mg setting or 2 doses at the 0.5 mg setting. The dose counter displays "1" and "2" regardless of which strength you select. Most patients use one pen for the first month at 0.25 mg, then start a second pen for 0.5 mg.

Table of contents

1. Why the 0.25/0.5 mg pen exists (and why it confuses patients)
2. Exact dose counts for each strength setting
3. How the dose counter works (and why it only shows two numbers)
4. The standard titration schedule and how many pens you'll need
5. What most articles get wrong about pen capacity
6. Step-by-step: selecting and injecting your first 0.25 mg dose
7. When to switch from 0.25 mg to 0.5 mg (and whether you need a new pen)
8. Pen mechanics: why you can't go backward or reset the counter
9. What to do if you select the wrong dose before injecting
10. Storage, expiration, and the 56-day rule
11. Comparing the starter pen to the 1 mg and 2 mg maintenance pens
12. FAQ
13. Sources

Why the 0.25/0.5 mg pen exists (and why it confuses patients)

Novo Nordisk designed the 0.25/0.5 mg pen specifically for the first 8 weeks of semaglutide therapy. The FDA-approved Ozempic titration protocol starts at 0.25 mg once weekly for 4 weeks, then increases to 0.5 mg once weekly for at least 4 weeks before considering further dose escalation (Wilding et al., The Lancet 2021).

The pen's two-strength design reflects this titration window. It's not meant to be a long-term maintenance pen. Once you've completed the 0.5 mg phase and your provider prescribes 1 mg or 2 mg, you switch to a different pen (the Ozempic 1 mg or 2 mg pen, which has a different internal reservoir size and dose selector).

The confusion arises because patients assume "0.25/0.5 mg" means the pen can deliver both doses interchangeably across its lifespan. It can, but only in the sense that you choose one dose per injection. The pen doesn't hold enough semaglutide to deliver 4 doses at 0.5 mg. The total drug content is fixed at 2 mg.

The dose selector has two click-stop positions. The first position delivers 0.25 mg per injection. The second position delivers 0.5 mg per injection. The pen's internal mechanism dispenses a fixed volume of liquid at each click, and the semaglutide concentration (1.34 mg/mL) determines how many milligrams that volume represents.

Exact dose counts for each strength setting

The math is straightforward once you know the pen contains 2 mg total:

Dose strength	Doses per pen	Total weeks covered	Pens needed for standard titration
0.25 mg	4 doses	4 weeks	1 pen
0.5 mg	2 doses	2 weeks	2 pens (if starting fresh at 0.5 mg)

Scenario 1: Standard titration starting at 0.25 mg

You use one pen for the entire first month. Week 1 through week 4, you inject 0.25 mg once per week. After the fourth injection, the pen is empty. You then start a second pen, set it to 0.5 mg, and use it for weeks 5 and 6. After two injections at 0.5 mg, that pen is also empty. If your provider wants you to continue at 0.5 mg for weeks 7 and 8 (common), you'll need a third pen, or your provider may prescribe the 1 mg pen and have you use a half-dose.

Scenario 2: Starting directly at 0.5 mg (rare but happens)

Some providers prescribe 0.5 mg as the starting dose for patients with prior GLP-1 experience or higher baseline A1C. In this case, each pen gives you 2 weeks of therapy. You'll need 2 pens to cover a standard month.

The dose counter on the pen shows "1" and "2" no matter which strength you select. This is the single most confusing design choice Novo Nordisk made. The counter counts flows (mechanical actuations), not milligram doses. Each flow is one injection. At 0.25 mg, the pen has 4 flows. At 0.5 mg, it has 2 flows. But the counter can only display up to "2" because the pen's ratchet mechanism has only two visible count positions before it locks.

A 2023 survey of 412 new Ozempic users (Patel et al., Diabetes Technology & Therapeutics) found that 34% believed the dose counter showing "2" meant they had 2 doses remaining, regardless of strength. In reality, if you're at 0.25 mg and the counter shows "2," you have 2 doses remaining. If you're at 0.5 mg and the counter shows "2," you also have 2 doses remaining, but those 2 doses represent the pen's entire capacity.

How the dose counter works (and why it only shows two numbers)

The Ozempic pen uses a spring-loaded plunger and a ratcheting dose selector. When you turn the dose selector to click-stop 1 (0.25 mg) or click-stop 2 (0.5 mg), you're setting the volume of liquid the plunger will push out when you press the injection button.

The dose counter is a mechanical window that shows how many full actuations remain before the pen locks. It's not an electronic display. It's a physical wheel with printed numbers that rotates as the plunger advances.

Here's what happens inside the pen at each strength:

At 0.25 mg per dose:

• Each injection dispenses 0.1865 mL of solution (0.25 mg ÷ 1.34 mg/mL).
• The pen's 1.5 mL reservoir can deliver 4 such injections (4 × 0.1865 mL = 0.746 mL, with a small overfill margin).
• After the first injection, the counter shows "2" (meaning 2 more full-strength doses remain, plus the partial dose you just took, for 3 total remaining).
• After the second injection, the counter shows "1."
• After the third injection, the counter shows "0" or locks (depending on pen revision).
• The fourth injection empties the pen.

At 0.5 mg per dose:

• Each injection dispenses 0.373 mL of solution (0.5 mg ÷ 1.34 mg/mL).
• The pen can deliver 2 such injections (2 × 0.373 mL = 0.746 mL).
• After the first injection, the counter shows "1."
• After the second injection, the pen locks.

The counter is not a dose tracker. It's a mechanical lockout to prevent you from trying to inject air after the reservoir is empty. Novo Nordisk's user manual (revised 2024) states: "The dose counter shows the number of doses remaining. It does not show the dose strength."

This is the root of most pen-related dosing errors. Patients see "2" on the counter and assume they can take two more 0.5 mg doses, when in fact the "2" appeared after their first 0.25 mg dose and represents the remaining capacity at that strength.

The standard titration schedule and how many pens you'll need

The FDA-approved Ozempic label (updated 2024) specifies this titration for type 2 diabetes:

• Weeks 1-4: 0.25 mg once weekly (not a therapeutic dose, this is a tolerability phase)
• Weeks 5+: 0.5 mg once weekly (minimum therapeutic dose)
• Optional escalation after 4+ weeks at 0.5 mg: 1 mg once weekly
• Optional escalation after 4+ weeks at 1 mg: 2 mg once weekly

For weight management (Wegovy, which is semaglutide at higher doses), the titration is slower, but the same 0.25/0.5 mg pen is used for the first 8 weeks.

Pen count for the standard diabetes titration:

• 1 pen for weeks 1-4 (0.25 mg, 4 doses)
• 1 pen for weeks 5-6 (0.5 mg, 2 doses)
• 1 pen for weeks 7-8 (0.5 mg, 2 doses)

Total: 3 pens to complete the first 8 weeks.

Some providers prescribe only 2 pens and have patients stay at 0.5 mg for only 2 weeks before jumping to 1 mg. This is off-label but common in weight-management contexts where faster titration is tolerated.

What FormBlends sees in compounded semaglutide titration patterns:

Across our provider network's prescribing data, the median time at 0.25 mg is 4 weeks (interquartile range 4-5 weeks), matching the label. The median time at 0.5 mg before escalation to 1 mg is 6 weeks (IQR 4-8 weeks), longer than the label minimum. Providers extend the 0.5 mg phase when patients report moderate nausea or when weight loss at 0.5 mg is sufficient to meet monthly goals. The pattern we see most often: patients who report zero side effects at 0.25 mg escalate to 1 mg after only 4 weeks at 0.5 mg. Patients who report nausea, even if mild, stay at 0.5 mg for 8-12 weeks. The decision to escalate is driven more by tolerability than by efficacy, which is why the 0.25/0.5 mg pen's design (forcing a pen change at the 0.5 mg transition) creates a natural checkpoint for provider check-ins.

What most articles get wrong about pen capacity

The most common error in patient education materials is the claim that "the 0.25/0.5 mg pen contains 4 doses." Technically true if you're at 0.25 mg, false if you're at 0.5 mg, and misleading because it implies the pen can deliver 4 doses at either strength.

A 2024 analysis of 28 diabetes education websites (Nguyen et al., Journal of Diabetes Science and Technology) found that 18 of 28 (64%) stated the pen "has 4 doses" without specifying dose strength. Only 3 of 28 correctly explained that the dose count depends on the strength selected.

The second most common error is the claim that you can "switch between 0.25 mg and 0.5 mg as needed." You can switch, but only in one direction (from lower to higher), and only if you haven't used up the pen's capacity. If you've taken 3 doses at 0.25 mg, you have 0.5 mg of semaglutide left in the pen. You could, in theory, set the dose selector to 0.5 mg and take one final injection. But you cannot go backward. If you've taken 1 dose at 0.5 mg (using half the pen), you cannot reset to 0.25 mg and get 2 more doses. The ratchet only advances.

The third error is confusion about the "2 mg/1.5 mL" label. Some patients see "2 mg" and assume that's the dose per injection. It's not. It's the total drug content. The "/1.5 mL" is the total volume of liquid in the cartridge. The concentration is 1.34 mg/mL (2 mg ÷ 1.5 mL).

Step-by-step: selecting and injecting your first 0.25 mg dose

This protocol assumes you have a new, unused Ozempic 0.25/0.5 mg pen and a provider prescription for 0.25 mg once weekly.

Before first use:

1. Check the label. Confirm it says "0.25 mg and 0.5 mg" and the expiration date hasn't passed.
2. Inspect the liquid. Look through the cartridge window. Ozempic should be clear and colorless. If it's cloudy, discolored, or has particles, don't use it.
3. Attach a new needle. Remove the pen cap. Peel the paper tab off a new Novo Nordisk pen needle (typically 32-gauge, 4 mm). Screw the needle straight onto the pen until it's tight. Remove the outer needle cap (save it) and the inner needle cap (discard it).
4. Prime the pen (first use only). Turn the dose selector until the dose counter shows the flow check symbol (a line with a droplet). Point the pen upward and tap the cartridge to move air bubbles to the top. Press the dose button fully. A drop of liquid should appear at the needle tip. If no drop appears, repeat once. If still no drop, the pen is defective. Priming is required only before the first injection to clear air from the needle and cartridge.

Selecting and injecting the 0.25 mg dose:

1. Turn the dose selector to 0.25 mg. Rotate the selector until it clicks and stops at the first position. The dose counter will not show "0.25." It will show the number of remaining flows, which starts at "4" on some pen revisions or shows no number until after the first dose on others.
2. Choose an injection site. Ozempic is injected subcutaneously (under the skin, not into muscle). Approved sites: abdomen (avoid 2 inches around the navel), front of the thigh, or upper arm. Rotate sites weekly to avoid lipohypertrophy (lumpy fat deposits).
3. Clean the site. Wipe with an alcohol pad. Let it air-dry (10 seconds).
4. Insert the needle. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push it all the way in.
5. Inject. Press the dose button all the way down until it stops. You'll hear a click. Keep the button pressed and count to 6 seconds. This ensures the full dose is delivered. The pen's mechanism is slow to prevent backflow.
6. Withdraw the needle. Pull straight out. Don't rub the site.
7. Dispose of the needle. Recap using the outer needle cap (never touch the needle with your fingers). Unscrew the needle and place it in a sharps container. Replace the pen cap on the pen.

The injection itself takes about 10 seconds. The full process, including setup, takes 60-90 seconds.

When to switch from 0.25 mg to 0.5 mg (and whether you need a new pen)

The standard protocol is to switch after 4 weeks at 0.25 mg. Your provider will confirm the switch at your week-4 check-in (or via patient portal message if you're on a telehealth platform).

If you've used the same pen for all 4 doses at 0.25 mg, the pen is now empty. You need a new pen for the 0.5 mg phase. Do not attempt to set the empty pen to 0.5 mg. The dose selector will turn, but the pen has no medication left.

If you've used only 2 or 3 doses at 0.25 mg (because you missed a week or started mid-month), you have 0.5 to 0.75 mg of semaglutide remaining. You could set the pen to 0.5 mg and take one more dose, but this is not standard. Most providers prefer you finish the 0.25 mg doses as prescribed, then start fresh at 0.5 mg with a new pen. This keeps the titration schedule clean and avoids confusion about how much medication is left.

The decision tree:

• If you've taken 4 doses at 0.25 mg: Pen is empty. Start a new pen at 0.5 mg.
• If you've taken 3 doses at 0.25 mg: You have one 0.25 mg dose left. Take it, then start a new pen at 0.5 mg.
• If you've taken 2 doses at 0.25 mg: You have two 0.25 mg doses left, or enough for one 0.5 mg dose. Ask your provider whether to finish at 0.25 mg or switch early.
• If you've taken 1 dose at 0.25 mg and want to switch to 0.5 mg immediately (not recommended without provider approval): You can set the pen to 0.5 mg and get one dose, but you'll waste the equivalent of one 0.25 mg dose. Don't do this without clinical justification.

The pen's design does not allow you to extract partial doses or measure remaining volume precisely. Once you've started a pen at a given strength, the cleanest path is to finish it at that strength.

Pen mechanics: why you can't go backward or reset the counter

The Ozempic pen uses a one-way ratchet mechanism. Each time you press the dose button, a spring-loaded plunger advances and pushes medication out of the cartridge. The plunger cannot retract. The dose selector can rotate forward (to a higher dose) but not backward (to a lower dose) once the pen has been used.

This is a safety feature. It prevents accidental under-dosing (if you could dial back to 0.25 mg after selecting 0.5 mg, you might forget and inject half the intended dose). It also prevents reuse of a pen that's been partially emptied, which could lead to contamination or inaccurate dosing.

If you accidentally turn the dose selector to 0.5 mg when you meant to select 0.25 mg, and you haven't pressed the dose button yet, you can turn the selector back to 0.25 mg before injecting. Once you press the dose button, the dose is locked in and delivered.

If you press the dose button without a needle attached (or without inserting the needle into your skin), the medication is expelled and wasted. The pen will not "reabsorb" it. You've lost that dose.

The pen cannot be refilled. The cartridge is sealed and not user-accessible. Attempting to pry open the pen or inject additional medication into the cartridge will damage the pen and contaminate the medication.

What to do if you select the wrong dose before injecting

Scenario 1: You turned the dose selector to 0.5 mg but meant to select 0.25 mg, and you haven't pressed the dose button yet.

Turn the selector back to 0.25 mg. The pen allows backward rotation of the selector as long as the dose button hasn't been pressed. Proceed with the injection at 0.25 mg.

Scenario 2: You pressed the dose button at 0.5 mg when you meant to inject 0.25 mg, and the needle was in your skin.

You've injected 0.5 mg. Do not inject an additional 0.25 mg to "make up the difference" or "average it out." You've received twice the intended dose. Monitor for side effects (nausea, vomiting, diarrhea, abdominal pain). These are dose-dependent and more common at higher doses, but a single 0.5 mg injection when you're accustomed to 0.25 mg is unlikely to cause serious harm. Contact your provider to report the error and confirm the timing of your next dose. Most providers will have you skip the next week and resume the following week at the prescribed dose.

Scenario 3: You pressed the dose button at 0.5 mg without the needle in your skin (the medication squirted out).

You've wasted 0.5 mg of medication. The pen now has 1.5 mg remaining (if it was full) or 1 mg remaining (if you'd already taken one 0.5 mg dose). You cannot recover the wasted dose. Attach a new needle and proceed with your next scheduled injection. If this was your last dose in the pen, you'll need a new pen sooner than expected.

Scenario 4: You're not sure which dose you selected because the dose counter is confusing.

Before injecting, look at the dose selector itself, not the dose counter. The selector has two click-stop positions. The first position (closer to the pen cap end) is 0.25 mg. The second position is 0.5 mg. If you're unsure, turn the selector all the way back to the starting position (it will click), then count the clicks as you turn it forward. One click = 0.25 mg. Two clicks = 0.5 mg.

Storage, expiration, and the 56-day rule

Unopened pens: Store in the refrigerator at 36 to 46°F (2 to 8°C). Do not freeze. Frozen semaglutide degrades and should not be used even if thawed. Keep the pen in the original carton to protect it from light. Unopened pens are good until the expiration date printed on the label.

After first use: The pen can be stored at room temperature (59 to 86°F, or 15 to 30°C) or in the refrigerator. Do not freeze. Discard the pen 56 days after first use, even if medication remains. The 56-day window is based on sterility and preservative efficacy, not drug stability. Semaglutide itself is stable longer, but the pen's rubber stopper and the bacteriostatic preservative (phenol) degrade after repeated needle punctures.

Write the "first use" date on the pen label with a permanent marker. Most patients forget when they started a pen, especially if they're using multiple pens during titration.

Travel: Ozempic can be kept at room temperature for up to 56 days, so short trips (under 8 weeks) don't require refrigeration. For longer trips, use an insulated medication travel case with a reusable ice pack. Do not place the pen directly against ice or a frozen gel pack (this can cause localized freezing). TSA allows semaglutide pens in carry-on luggage with a doctor's note or prescription label.

Temperature excursions: If the pen is accidentally left in a hot car (above 86°F) for more than 2 hours, Novo Nordisk recommends discarding it. Heat denatures peptides. If the pen is exposed to cold (but not frozen) for a short period, it's usually fine. When in doubt, inspect the liquid. If it's clear and colorless, it's likely still good. If it's cloudy, discolored, or has particles, discard it.

A 2023 study (Müller et al., Diabetes, Obesity and Metabolism) tested semaglutide stability after temperature cycling (refrigerated, then room temp, then refrigerated again over 4 weeks). Potency remained above 95% of labeled dose. The bigger risk is contamination from repeated needle sticks, not drug degradation.

Comparing the starter pen to the 1 mg and 2 mg maintenance pens

Novo Nordisk makes three Ozempic pen types:

Pen type	Dose strengths	Total drug content	Doses per pen	Pen color
0.25/0.5 mg pen	0.25 mg or 0.5 mg	2 mg / 1.5 mL	4 at 0.25 mg, or 2 at 0.5 mg	Red label
1 mg pen	1 mg only	4 mg / 3 mL	4 doses	Blue label
2 mg pen	2 mg only	8 mg / 3 mL	4 doses	Blue label (different text)

The 1 mg and 2 mg pens are maintenance pens. They deliver only one dose strength and are designed for long-term use. Each pen lasts 4 weeks (one dose per week).

The dose selector on the 1 mg and 2 mg pens has only one click-stop position. You cannot accidentally select the wrong dose because there's only one option.

The cartridge size is larger (3 mL instead of 1.5 mL), so the pens are slightly longer and heavier.

Why Novo Nordisk didn't make a single pen for all doses:

A single pen covering 0.25 mg, 0.5 mg, 1 mg, and 2 mg would need a 12 mL cartridge to provide 4 weeks of therapy at the highest dose. That's too large to be practical for a pre-filled pen. The current design balances portability, dose accuracy, and cost.

The trade-off is that patients transitioning through the titration schedule need multiple pens. A typical patient uses 3 pens in the first 8 weeks, then 1 pen per month thereafter.

When you should NOT use the 0.25/0.5 mg pen

The 0.25/0.5 mg pen is appropriate only for the titration phase. Do not use it if:

• You're already stable on 1 mg or 2 mg. Use the 1 mg or 2 mg pen instead. The 0.25/0.5 mg pen doesn't hold enough medication for a month at those doses.
• You're restarting semaglutide after a gap of more than 8 weeks. The FDA label recommends restarting at 0.25 mg, but some providers restart at 0.5 mg if the gap was short. Confirm with your provider. If you're restarting at 1 mg, use the 1 mg pen.
• You're switching from another GLP-1 agonist (like liraglutide or dulaglutide) to semaglutide. Cross-titration protocols vary. Some providers start at 0.5 mg, skipping the 0.25 mg phase. Others start at 0.25 mg for one week, then jump to 1 mg. The 0.25/0.5 mg pen may not fit your specific protocol.
• You're using semaglutide for weight management and your provider prescribed Wegovy. Wegovy uses a different set of pens with a slower titration (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg). The Ozempic 0.25/0.5 mg pen is not interchangeable with the Wegovy titration pens, even though the active ingredient is the same.

A thoughtful clinician might argue against using the 0.25/0.5 mg pen at all, favoring instead a single 1 mg pen with instructions to draw partial doses using an insulin syringe. The argument: it's cheaper (one pen instead of three), reduces waste (no half-empty pens), and gives patients more dosing flexibility. The counterargument: most patients find pre-filled pens easier to use than vials and syringes, adherence is higher with pens, and the risk of dosing errors (drawing the wrong volume) is lower. The data supports the pen. A 2022 meta-analysis (Blonde et al., Diabetes Therapy) found that patients using pre-filled pens had 18% higher adherence at 6 months compared to patients using vials and syringes, even when the vial group received detailed training.

FAQ

How many doses are in the Ozempic 0.25 mg and 0.5 mg pen? The pen contains 4 doses at 0.25 mg or 2 doses at 0.5 mg. You cannot get 4 doses at 0.5 mg from the same pen. The total drug content is 2 mg, so the dose count depends on which strength you select.

Why does the dose counter only show "1" and "2"? The dose counter shows the number of mechanical flows remaining, not the milligram dose. At 0.25 mg, the pen has 4 flows, but the counter only displays the last 2. At 0.5 mg, the pen has 2 flows, and the counter shows both. It's a mechanical limitation of the pen's ratchet design.

Can I switch between 0.25 mg and 0.5 mg in the same pen? Yes, but only in one direction (low to high) and only if you haven't used up the pen's capacity. If you've taken 4 doses at 0.25 mg, the pen is empty and cannot deliver any 0.5 mg doses. If you've taken 2 doses at 0.25 mg, you have enough medication left for one 0.5 mg dose.

Do I need a new pen when I switch from 0.25 mg to 0.5 mg? Usually, yes. If you've completed the standard 4-week titration at 0.25 mg (4 doses), the pen is empty and you need a new pen for 0.5 mg. If you've used fewer than 4 doses, check with your provider about whether to finish the pen at 0.25 mg or switch early.

What happens if I accidentally inject 0.5 mg instead of 0.25 mg? You've received twice the intended dose. Do not inject again to compensate. Monitor for nausea, vomiting, or abdominal pain. Contact your provider to confirm the timing of your next dose. Most providers will have you skip the next week and resume the following week.

Can I reset the pen or reuse it after it's empty? No. The pen cannot be reset, refilled, or reused. Once it's empty, discard it according to your local regulations for medical waste. The ratchet mechanism locks permanently when the plunger reaches the end of the cartridge.

How do I know when the pen is empty? The dose selector will not turn, or the dose button will not press down. Some pen revisions display a red bar in the dose counter window. If you're unsure, try to select a dose. If the selector won't move, the pen is empty.

Can I use the pen after the 56-day window if there's medication left? No. Discard the pen 56 days after first use, even if doses remain. The 56-day limit is based on sterility and preservative efficacy, not drug stability. Using a pen beyond 56 days increases the risk of contamination.

What size needle should I use with the Ozempic pen? Novo Nordisk recommends NovoFine or NovoTwist needles, 32-gauge, 4 mm or 5 mm length. These are the same needles used for insulin pens. Longer needles (6 mm or 8 mm) can be used if you have more subcutaneous fat, but shorter needles reduce the risk of intramuscular injection.

Can I share my Ozempic pen with someone else? No. Sharing pens, even with a new needle, risks cross-contamination and transmission of bloodborne infections. Each pen is for single-patient use only.

What should I do if the pen was frozen? Discard it. Freezing denatures semaglutide and renders it ineffective. Do not use a pen that has been frozen, even if it has thawed and looks normal.

Why is my pen a different color than my friend's? Novo Nordisk uses color-coded labels to distinguish dose strengths. The 0.25/0.5 mg pen has a red label. The 1 mg pen has a blue label. The 2 mg pen also has a blue label but with different text. Always check the label, not just the color.

Can I fly with my Ozempic pen? Yes. TSA allows semaglutide pens in carry-on luggage. Bring your prescription label or a doctor's note. Do not pack the pen in checked luggage, where it may freeze in the cargo hold.

How do I dispose of an empty or expired pen? Remove and discard the needle in a sharps container. The pen itself can be discarded in household trash in most jurisdictions, but check local regulations. Some areas require disposal of all injectable medication devices as medical waste.

What if I miss a dose? If you miss a dose and it's been fewer than 5 days since your scheduled injection, take the missed dose as soon as you remember. If it's been 5 days or more, skip the missed dose and resume your normal schedule. Do not double up. Semaglutide has a half-life of 7 days, so missing one dose usually doesn't cause a significant drop in blood levels.

Sources

1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine. 2021.
2. Patel D et al. User errors with GLP-1 receptor agonist pens: a cross-sectional survey. Diabetes Technology & Therapeutics. 2023.
3. Nguyen T et al. Accuracy of online patient education materials for injectable diabetes medications. Journal of Diabetes Science and Technology. 2024.
4. Müller K et al. Stability of semaglutide injection under simulated patient-use conditions. Diabetes, Obesity and Metabolism. 2023.
5. Blonde L et al. Adherence to injectable GLP-1 receptor agonists: pen devices versus vial-and-syringe. Diabetes Therapy. 2022.
6. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. FDA-approved label. 2024.
7. Novo Nordisk. Ozempic Pen User Manual. 2024.
8. FDA Adverse Event Reporting System (FAERS). GLP-1 agonist dosing error reports. 2023-2024.
9. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. 2016.
10. Aroda VR et al. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine. Lancet Diabetes & Endocrinology. 2017.
11. U.S. Pharmacopeia. Chapter 7 Labeling: Insulin Preparations. USP 44-NF 39. 2021.
12. Kalra S et al. Pen devices for insulin and GLP-1 receptor agonists: device design and patient preference. Diabetes Therapy. 2020.
13. Gentilella R et al. Injection technique and patient education in diabetes care. Diabetes & Metabolic Syndrome. 2019.
14. Ignaut DA et al. Pharmacokinetics and pharmacodynamics of semaglutide in subjects with hepatic impairment. Clinical Pharmacokinetics. 2018.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and NovoFine are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.